Comparison 8. Magnesium sulphate versus nimodipine.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Eclampsia	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	0.33 [0.14, 0.77]
2 Stroke	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	0.0 [0.0, 0.0]
3 Coagulopathy	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	0.59 [0.14, 2.47]
4 Respiratory problems	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	3.61 [1.01, 12.91]
5 Cardiac failure	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	4.93 [0.24, 102.49]
6 Respiratory depression	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	3.61 [1.01, 12.91]
7 Antihypertensive drug	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	1.19 [1.08, 1.31]
8 Oliguria	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	1.15 [0.79, 1.68]
9 Side effects	1		Risk Ratio (M‐H, Fixed, 95% CI)	Subtotals only
9.1 Flushing	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	4.47 [2.47, 8.09]
9.2 Nausea/vomiting	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	1.17 [0.81, 1.69]
9.3 Headache	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	0.94 [0.63, 1.40]
9.4 Hypotension	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	1.38 [0.44, 4.33]
10 Placental abruption	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	1.31 [0.46, 3.77]
11 Caesarean section	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	1.03 [0.94, 1.13]
12 Postpartum haemorrhage	1	1650	Risk Ratio (M‐H, Fixed, 95% CI)	2.46 [1.09, 5.56]
13 Respiratory distress syndrome	1	1564	Risk Ratio (M‐H, Fixed, 95% CI)	1.23 [0.84, 1.81]
14 Neonatal hypotonia	1	1564	Risk Ratio (M‐H, Fixed, 95% CI)	1.78 [0.91, 3.46]
15 Baby intubated	1	1564	Risk Ratio (M‐H, Fixed, 95% CI)	1.37 [0.91, 2.05]
16 Neonatal hypotension	1	1564	Risk Ratio (M‐H, Fixed, 95% CI)	0.32 [0.06, 1.58]